MRK vs SOLV
By Alex · Tickerpine
Merck & Co., Inc. vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SOLV |
|---|---|---|
| Price | $145.27 | $85.41 |
| Market cap | $358.41B | $14.54B |
| P/E ratio | 117.2 | 10.5 |
| ROE | 6.96% | 33.96% |
| Profit margin | 4.77% | 17.26% |
| Revenue growth | 5.10% | 2.20% |
| Dividend yield | 2.34% | 0.00% |
| Beta | 0.22 | 0.70 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SOLV in plain English
- MRK is the bigger company — about 24.7× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 10.5 vs 117.2).
- SOLV earns a higher return on equity (34% vs 7%).
- MRK is growing revenue faster (5% vs 2%).
- MRK pays a dividend (2.34%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.